Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

The proposed partnership with Essentia is responsive to needs and merits strong attention.

A preliminary estimate by education policy analyst James Murphy finds that the U stands to lose around $62 million annually ...

BLOOMINGTON — Parking bans have been issued in LeRoy, Bloomington and Normal ahead of the incoming winter storm. LeRoy Police ...

Less than a month after filing for Chapter 11 bankruptcy protection for the second time in a year, craft retailer JOANN is ...

Joanna Jackson, who suffered a heart attack in 2024, wants to raise awareness about Spontaneous Coronary Artery Dissection.